Invention Grant
- Patent Title: Methods and systems for interpretation and reporting of sequence-based genetic tests
-
Application No.: US14319986Application Date: 2014-06-30
-
Publication No.: US10665328B2Publication Date: 2020-05-26
- Inventor: Douglas E. Bassett, Jr. , Daniel R. Richards , Peer M. Schatz
- Applicant: QIAGEN Redwood City, Inc. , QIAGEN GmbH
- Applicant Address: US CA Redwood City DE Hilden
- Assignee: QIAGEN Redwood City, Inc.,QIAGEN GmbH
- Current Assignee: QIAGEN Redwood City, Inc.,QIAGEN GmbH
- Current Assignee Address: US CA Redwood City DE Hilden
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: G16B50/00
- IPC: G16B50/00 ; G16B20/00

Abstract:
Disclosed herein are system, method, and computer program product embodiments for aiding in the interpretation of variants observed in clinical sequencing data. An embodiment operates by receiving clinical trial enrollment criteria from a user, including but not limited to genetic targeting criteria; searching a knowledge base of patient test information received from a plurality of independent entities for patients that match the clinical trial enrollment criteria; and providing to the user search results for consented patients that match the clinical trial enrollment criteria.
Public/Granted literature
- US20150379193A1 METHODS AND SYSTEMS FOR INTERPRETATION AND REPORTING OF SEQUENCE-BASED GENETIC TESTS Public/Granted day:2015-12-31
Information query